Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr Ashley Bush joins scientific advisory board at Adeona

This article was originally published in Scrip

Executive Summary

Adeona Pharmaceuticals, an Ann Arbor, Michigan-based developer of medicines for serious central nervous system diseases, has elected Dr Ashley Bush to its scientific advisory board. He is a National Health and Medical Research Council Australia Fellow and head of the oxidation disorders laboratory for the Mental Health Research Institute, University of Melbourne. Dr Bush has also served as the director of the laboratory for oxidation biology, Massachusetts General Hospital, and associate professor of psychiatry at Harvard Medical School.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC012378

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel